Drug profile · INN
metyrosine
DEMSER
metyrosine (DEMSER) is a tyrosine 3-hydroxylase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — metyrosine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
metyrosine (DEMSER) is a tyrosine 3-hydroxylase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Tyrosine 3-hydroxylase inhibitor
Primary target: Tyrosine 3-monooxygenase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is metyrosine?
metyrosine (DEMSER) is a tyrosine 3-hydroxylase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for metyrosine?
DEMSER is a marketed brand name for metyrosine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metyrosine?
metyrosine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.